Isolated Limb Infusion Chemotherapy With Targeted Gene Therapy for Advanced, Unresectable Extremity Melanoma

NCT01531244 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Melanoma

Interventions

BIOLOGICAL: dactinomycin
DRUG: melphalan
BIOLOGICAL: Conditionally replicative adenovirus 3/5-delta

Sponsor

Washington University School of Medicine